Cargando…
Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force
The Australian Defence Force (ADF) has used mefloquine for malaria chemoprophylaxis since 1990. Mefloquine has been found to be a plausible cause of a chronic central nervous system toxicity syndrome and a confounding factor in the diagnosis of existing neuropsychiatric illnesses prevalent in the AD...
Autor principal: | McCarthy, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697095/ https://www.ncbi.nlm.nih.gov/pubmed/26793391 http://dx.doi.org/10.1155/2015/287651 |
Ejemplares similares
-
Mefloquine for preventing malaria in pregnant women
por: González, Raquel, et al.
Publicado: (2018) -
Mefloquine for preventing malaria in pregnant women
por: González, Raquel, et al.
Publicado: (2018) -
Mefloquine for preventing malaria during travel to endemic areas
por: Tickell‐Painter, Maya, et al.
Publicado: (2017) -
Signal detection to identify serious adverse events (neuropsychiatric events) in travelers taking mefloquine for chemoprophylaxis of malaria
por: Naing, Cho, et al.
Publicado: (2012) -
Prolonged Neuropsychiatric Symptoms in a Military Service Member Exposed to Mefloquine
por: Livezey, Jeffrey, et al.
Publicado: (2016)